I’m afraid this sounds to me like you have done very little...

I’m afraid this sounds to me like you have done very little background reading or research on this company. I implore you to do some reading before passing judgement. I thought the same until I did some digging.

The Top 20 have about 90% of the stock, which is very tightly held, and coronavirus has pushed this to unusual lows and provided a rare opportunity to an astute microcap investor.

They have a tangible product (actually several distinct product lines), global in scope, generating millions in revenue each year selling direct to blue chip clients. Market cap is 10m AUD.

I could equally dismiss your investment in HCT, which fell 34% today, as a loss making lifestyle company.